Efficacy and safety of additional olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting: A randomized, double-blind, placebo-controlled, crossover study

Autor:	Nattaya Sintawichai, Suleepon Uttamapinan, Veerisa Vimolchalao, Chanida Vinayanuwattikun, Ploytuangporn Wongchanapai, Siwat Sakdejayont, Sutima Luangdilok, Virote Sriuranpong, Nattaya Poovorawan, Napa Parinyanitikul, Suebpong Tanasanvimon, Shama Sukprakun
Rok vydání:	2018
Předmět:	Olanzapine Cancer Research Nausea business.industry Palonosetron Placebo Crossover study Ondansetron Oncology Anesthesia medicine medicine.symptom business Dexamethasone medicine.drug Chemotherapy-induced nausea and vomiting
Zdroj:	Journal of Clinical Oncology. 36:10019-10019
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2018.36.15_suppl.10019
Popis:	10019Background: Currently, the antiemetic regimen consisting of dexamethasone, palonosetron plus a NK-1 antagonist or olanzapine is recommended in prevention of chemotherapy induced nausea and vom...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::54736734a052c72a9ce592d0f92e2e89 https://doi.org/10.1200/jco.2018.36.15_suppl.10019 Zobrazit plný text záznamu